Professional
Added to YB: 2024-10-25
Pitch date: 2024-10-21
MEDP [bullish]
Medpace Holdings, Inc.
+62.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$305.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Giverny Capital Asset Management New Position: Medpace Holdings, Inc.
MEDP: CRO for early-stage biopharma. 17% insider-owned. High ROIC, margins, FCF. Expertise in identifying promising biotech startups. Never cheap; bought at 25x fwd earnings. Biotech funding healthy, potential rate cut tailwind. New 2.5% position established.
Read full article (2 min)